
Jordi Antón López
Jefe de Grupo Senior
Research group
Jordi Antón López is a Paediatric rheumatologist, Head of Section of the Paediatric Rheumatology Unit at the SJD Barcelona Children's Hospital. Doctor in Medicine from the University of Barcelona, of which he is an associate professor. Since 2013 he has been the director of the master's degree in Paediatric Rheumatology at the same university.
He has been the president of the Spanish Society of Paediatric Rheumatology (SERPE) (2011-2019), and is currently chair of the Education and Training Committee and member of the Council of PRES (Paediatric Rheumatology European Society) and active member of PRINTO (Paediatric Rheumatology International Trials Association). Director of the Study group of diseases due to immune dysfunction in Paediatrics (GEMDIP) recognized as a Pre-Consolidated Group by the Catalan Agency for Management of University and Research Grants (AGAUR) (2017 SGR 1547) and framed within the line on Infectious Diseases and Systemic Immune Response of the Sant Joan de Déu Research Institute (IRSJD).
He has participated as a researcher in 22 R+D+i projects financed in competitive calls of Administrations or public and private entities, and in 33 R & D contracts, agreements or projects that are not competitive with public or private administrations or entities. He has directed doctoral thesis in Kawasaki disease and autoinflammatory diseases.
With 103 publications, its H index is 29. The sum of Impact Factor is 710,355, with 3.273 total citations. In the last 5 years the number of publications is 63, of them 42 in the first quartile and 27 in the first decile, with a sum of the impact factor of the last 5 years of 461,607.
Professional network profiles
Related websites
Last Publications
- Ruperto N, Lovell DJ, Berman A, Anton-Lopez J, Viola DO, Lauwerys B, Rama ME, Bohnsack J, Breedt J, Fischbach M, Lutz T, Minden K, Ally M, Rubio-Pérez N, Gervais E, Van Zyl R, Wong R, Askelson M, Martini A and Brunner HI Abatacept as Monotherapy and in Combination With Methotrexate in Patients With Juvenile Idiopathic Arthritis: Analysis of 2 Phase III Trials. JOURNAL OF RHEUMATOLOGY . 50(11): 1471-1480.
- Fonollosa A, Pelegrín L, García-Morillo S, Buján-Rivas S, Distefano L, Robles-Maruenda A, Fernández-Martín J, González-García A, Garcia-Aparicio Á, Ortego-Centeno N, Llorenç V, Sainz de la Maza M, Pinedo C, Sopeña B, Cocho L, Carreño E, Blanco R, Anton-Lopez J, Pérez-Quintana M, Marques-Soares JR, Artaraz J, Ruiz-Arruza I, Soto-Peleteiro A, Gómez-Caverzaschi V, Araújo O, Espinosa G, Adan A, Fabiani C, Cantarini L and Hernández-Rodríguez J Ocular involvement in adult and paediatric patients with monogenic autoinflammatory diseases: a Spanish multicentre retrospective study. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY . 41(10): 2105-2114.
- Gerritsma AM, Sutera D, Cantarini L, Cattalini M, Lachmann HJ, Minden K, Jansson AF, Touitou I, Bustaffa M, Anton-Lopez J, Insalaco A, Moreno E, Sanchez-Manubens J, Ruperto N, Frenkel J and Gattorno M TNFRSF1A-pR92Q variant identifies a subset of patients more similar to systemic undifferentiated recurrent fever than TNF receptor-associated periodic syndrome. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY . 41(10): 1998-2007.
Projects
- Project name:
- Estudio piloto para la creación de un “command center” clínico en un servicio de reumatología pediátrica
- Leader
- Jordi Antón López
- Funding entities:
- Sociedad Española de Reumatología Pediátrica (SERPE)
- Code
- PCP00363
- Starting - finishing date:
- 2022 - 2024
- Project name:
- Mejoría en la monitorización, atención y calidad de vida de pacientes con Artritis idiopática juvenil mediante el uso de nuevas tecnologías (proyecto MACAI)
- Leader
- Jordi Antón López
- Funding entities:
- ZZZZ_O.H.S.J.D.-Curia Provincial, Provincia San Juan de Dios de España
- Code
- Beca Bombers 2021
- Starting - finishing date:
- 2022 - 2024
- Project name:
- Producing an Arthritis Value-Framework with Economic Evidence
- Leader
- Jordi Antón López
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- AC21_2/00034
- Starting - finishing date:
- 2022 - 2024
News
-
Mutation in DOCK11 gene explains rare disorder in immune system regulation
Researchers from the Institut de Recerca Sant Joan de Déu - SJD Barcelona Children's Hospital participate in an international study, published in the prestigious scientific journal New England Journal of Medicine, which describes for the first time a new disease of the immune system caused by a mutation of the DOCK11 gene.
-
The european ImmunAID project starts its clinical phase
The ImmunAID project aims to develop new diagnostic signatures for systemic auto-inflammatory diseases (SAID). Ultimately, the aim is to offer better care for these rare disease patients. Systemic auto-inflammatory diseases (SAID) are a complex and poorly understood group of rare diseases.